{"pageContent": "Objective: Prostate cancer is a common malignancy and patients may progress to castration-resistant prostate cancer (CRPC). Among patients with CRPC, fatigue is a common symptom associated with current treatments. The aim of this real-world study was to describe patient-reported fatigue in Japanese patients treated with androgen receptor-axis-targeted therapies for CRPC.", "metaData": {"source": "The views of patients with metastatic prostate cancer towards physical activity: a qualitative exploration\nhttps://pubmed.ncbi.nlm.nih.gov/29243168/"}}